OACCW — Oaktree Acquisition Corp. III Life Sciences
—
Nasdaq ·
Financials ·
Diversified Financial Services ·
CIK 2029769 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | 1,179,670 | — |
| Mar 2026 | 0 | — | -456,538 | 1,394,121 | 204,830,388 | 1,276,930 | 8,642,892 |
| Dec 2025 | 0 | — | -255,496 | 1,788,948 | 203,111,772 | 1,434,965 | 8,318,397 |
| Sep 2025 | 0 | — | -225,579 | 1,966,742 | 201,249,963 | 1,328,841 | 8,245,536 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-504,552
Investing CF
$250,000
Financing CF
—
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-7,227,233
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-1,207,423
Pretax Income TTM
$7,024,154
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -1,195,687 | 7,288,824 | 203,111,772 | 8,318,397 | 194,793,375 | -422,079 |
| Dec 2024 | — | — | — | 195,250,622 | 7,746,071 | 187,504,551 | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HASI | HA Sustainable Infrastructure Capital, Inc. | $4.68B | $36.44 | — |
| DMII | Drugs Made In America Acquisition II Corp. | $647.19M | $10.16 | — |
| EVAC | EQV Ventures Acquisition Corp. II | $484.03M | $10.31 | — |
| BCSS | Bain Capital GSS Investment Corp. | $483.54M | $10.31 | — |
| CEPF | Cantor Equity Partners IV, Inc. | $472.77M | $10.30 | — |
Recent Insider Activity
No insider activity indexed for this ticker.